FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY

K Number: K964765 · Decision Feb 14, 1997
Classifications
1
FEI Numbers
20
Registration Numbers
20
Same Product Code
55
Applicant Total
20
Review Days
79

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY
K Number
K964765
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3645
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Chiron Diagnostics Corp.
Date Received
November 27, 1996
Decision Date
February 14, 1997
Product Code
KLT
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
KLT Enzyme Immunoassay, Carbamazepine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (KLT), ordered by most recent decision date.

View all

Other Clearances by Chiron Diagnostics Corp.

K Number Device Name
K992157 CHIRON DIAGNOSTICS ACS: 180 FERRITIN ASSAY
K991582 CHIRON DIAGNOSTICS ACS: 180 FOLATE
K991692 CHIRON DIAGNOSTICS ACS: 180 FT3
K982680 CHIRON DIAGNOSTICS CORPORATION ACS: CENTAUR BR IMMUNOASSAY
K981478 ACS:CENTAUR CEA
K981839 ACS:CENTAUR PSA2 IMMUNOASSAY
K981592 ACS:CENTAUR AFP
K980528 CHIRON DIAGNOSTICS ACS:180 TROPONIN I ASSAY (CTNI)
K974029 ACS TOBRAMYCIN
K974325 CHIRON DIAGNOSTICS ACS:180 MYOGLOBIN
Search all 20 clearances from Chiron Diagnostics Corp. →